Search Results

There are 6298 results for: content related to: Phase II randomized study of daily gefitinib treatment alone or with vinorelbine every 2 weeks in patients with adenocarcinoma of the lung who failed at least 2 regimens of chemotherapy

  1. Non-Small-Cell Lung Cancer

    Standard Article

    Wiley Handbook of Current and Emerging Drug Therapies

    Published Online : 15 SEP 2006, DOI: 10.1002/9780470041000.cedt012

  2. You have free access to this content
    First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer

    Intervention Review

    The Cochrane Library

    Janette Greenhalgh, Kerry Dwan, Angela Boland, Victoria Bates, Fabio Vecchio, Yenal Dundar, Pooja Jain and John A Green

    Published Online : 25 MAY 2016, DOI: 10.1002/14651858.CD010383.pub2

  3. You have free access to this content
    Gefitinib and chemotherapy combination studies in five novel human non small cell lung cancer xenografts. Evidence linking EGFR signaling to gefitinib antitumor response

    International Journal of Cancer

    Volume 120, Issue 7, 1 April 2007, Pages: 1579–1590, Jean-Gabriel Judde, Magali Rebucci, Nicolas Vogt, Patricia de Cremoux, Alain Livartowski, Alain Chapelier, Carine Tran-Perennou, Karine Boye, Rémy Defrance, Marie-France Poupon and Rui-Alberto Bras-Gonçalves

    Version of Record online : 4 JAN 2007, DOI: 10.1002/ijc.22364

  4. You have free access to this content
    Poster Presentation – Lung Cancer


    Volume 19, Issue S3, November 2014, Pages: 154–172,

    Version of Record online : 30 OCT 2014, DOI: 10.1111/resp.12417_10

  5. Physicochemical properties of epidermal growth factor receptor inhibitors and development of a nanoliposomal formulation of gefitinib

    Journal of Pharmaceutical Sciences

    Volume 101, Issue 8, August 2012, Pages: 2763–2776, Brian J. Trummer, Vandana Iyer, Sathy V. Balu-Iyer, Robert O'Connor and Robert M. Straubinger

    Version of Record online : 11 MAY 2012, DOI: 10.1002/jps.23180

  6. You have full text access to this Open Access content
    VEGF neutralizing antibody increases the therapeutic efficacy of vinorelbine for renal cell carcinoma

    Journal of Cellular and Molecular Medicine

    Volume 14, Issue 3, March 2010, Pages: 647–658, Sutapa Sinha, Ying Cao, Shamit Dutta, Enfeng Wang and Debabrata Mukhopadhyay

    Version of Record online : 7 NOV 2008, DOI: 10.1111/j.1582-4934.2008.00578.x

  7. You have full text access to this Open Access content
    Amrubicin, a novel 9-aminoanthracycline, enhances the antitumor activity of chemotherapeutic agents against human cancer cells in vitro and in vivo

    Cancer Science

    Volume 98, Issue 3, March 2007, Pages: 447–454, Mitsuharu Hanada, Toshihiro Noguchi and Takashi Yamaoka

    Version of Record online : 10 JAN 2007, DOI: 10.1111/j.1349-7006.2007.00404.x

  8. ErbB family receptor inhibitors as therapeutic agents in breast cancer: Current status and future clinical perspective

    Medicinal Research Reviews

    Volume 32, Issue 1, January 2012, Pages: 166–215, Ruchi Saxena and Anila Dwivedi

    Version of Record online : 25 OCT 2010, DOI: 10.1002/med.20209

  9. You have free access to this content
    Gefitinib in advanced non-small cell lung cancer: Clinical experience in patients of Asian origin

    Asia-Pacific Journal of Clinical Oncology

    Volume 3, Issue 2, June 2007, Pages: 66–78, Alison ARMOUR

    Version of Record online : 4 JUN 2007, DOI: 10.1111/j.1743-7563.2007.00090.x

  10. You have free access to this content
    Bystander effect of vinorelbine alters antitumor immune response

    International Journal of Cancer

    Volume 129, Issue 6, 15 September 2011, Pages: 1511–1518, Audrey Thomas-Schoemann, François Lemare, Céline Mongaret, Elisabeth Bermudez, Christiane Chéreau, Carole Nicco, Alain Dauphin, Bernard Weill, François Goldwasser, Frédéric Batteux and Jérôme Alexandre

    Version of Record online : 1 APR 2011, DOI: 10.1002/ijc.25813

  11. You have free access to this content
    Vinorelbine-based salvage chemotherapy for therapy-refractory aggressive leukaemias

    British Journal of Haematology

    Volume 135, Issue 4, November 2006, Pages: 500–508, Fatih M. Uckun, Sanda Morar and Sanjive Qazi

    Version of Record online : 13 OCT 2006, DOI: 10.1111/j.1365-2141.2006.06338.x

  12. You have free access to this content
    Chemotherapy for advanced non-small cell lung cancer in the elderly population

    Intervention Review

    The Cochrane Library

    Fábio N Santos, Tiago B de Castria, Marcelo RS Cruz and Rachel Riera

    Published Online : 20 OCT 2015, DOI: 10.1002/14651858.CD010463.pub2

  13. You have free access to this content
    Vinorelbine and epirubicin share common features with polysialic acid and modulate neuronal and glial functions

    Journal of Neurochemistry

    Volume 136, Issue 1, January 2016, Pages: 48–62, Gabriele Loers, Vedangana Saini, Bibhudatta Mishra, Sheraz Gul, Sidhartha Chaudhury, Anders Wallqvist, Gurcharan Kaur and Melitta Schachner

    Version of Record online : 6 NOV 2015, DOI: 10.1111/jnc.13383

  14. The emerging role of epidermal growth factor receptor inhibitors in ovarian cancer

    International Journal of Gynecological Cancer

    Volume 18, Issue 5, September/October 2008, Pages: 879–890, M.J. PALAYEKAR and T.J. HERZOG

    Version of Record online : 5 DEC 2007, DOI: 10.1111/j.1525-1438.2007.01144.x

  15. You have free access to this content
    Targeted therapy: An evolving world of lung cancer


    Volume 16, Issue 1, January 2011, Pages: 13–21, Kwok-Chi LAM and Tony S. MOK

    Version of Record online : 16 AUG 2010, DOI: 10.1111/j.1440-1843.2010.01821.x

  16. Encapsulation of vinorelbine into cholesterol-polyethylene glycol coated vesicles: drug loading and pharmacokinetic studies

    Journal of Pharmacy and Pharmacology

    Volume 63, Issue 3, March 2011, Pages: 376–384, ChunLei Li, JingXia Cui, CaiXia Wang, Lan Zhang, Xian Xiu, YongFeng Li, Na Wei, YanHui Li and Li Zhang

    Version of Record online : 8 FEB 2011, DOI: 10.1111/j.2042-7158.2010.01227.x

  17. You have free access to this content
    Potential role of molecularly targeted therapy in the management of advanced nonsmall cell lung carcinoma in the elderly


    Volume 101, Issue 8, 15 October 2004, Pages: 1733–1744, Cesare Gridelli, Erminia Massarelli, Paolo Maione, Antonio Rossi, Roy S. Herbst, Amir Onn and Fortunato Ciardiello

    Version of Record online : 8 SEP 2004, DOI: 10.1002/cncr.20572

  18. You have free access to this content
    Second-line treatments after first-line gefitinib therapy in advanced nonsmall cell lung cancer

    International Journal of Cancer

    Volume 126, Issue 1, 1 January 2010, Pages: 247–255, Jenn-Yu Wu, Jin-Yuan Shih, Chih-Hsin Yang, Kuan-Yu Chen, Chao-Chi Ho, Chong-Jen Yu and Pan-Chyr Yang

    Version of Record online : 17 JUN 2009, DOI: 10.1002/ijc.24657

  19. A Systematic Review of Vinorelbine for the Treatment of Breast Cancer

    The Breast Journal

    Volume 19, Issue 2, March/April 2013, Pages: 180–188, Ying-Chun Xu, Hong-Xia Wang, Lei Tang, Yue Ma and Feng-Chun Zhang

    Version of Record online : 16 JAN 2013, DOI: 10.1111/tbj.12071

  20. You have free access to this content
    Phase 2 trial of docetaxel and gefitinib in the first-line treatment of patients with advanced nonsmall-cell lung cancer (NSCLC) who are 70 years of age or older


    Volume 112, Issue 9, 1 May 2008, Pages: 2021–2029, George R. Simon, Martine Extermann, Alberto Chiappori, Charles C. Williams, Mubeena Begum, Rachna Kapoor, Eric B. Haura, Roohi Ismail-Khan, Michael J. Schell, Scott J. Antonia and Gerold Bepler

    Version of Record online : 25 FEB 2008, DOI: 10.1002/cncr.23360